NasdaqCM - Delayed Quote USD

Predictive Oncology Inc. (POAI)

1.6600 +0.3200 (+23.88%)
At close: April 25 at 4:00 PM EDT
1.6800 +0.02 (+1.20%)
After hours: April 25 at 7:48 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,780.0930
1,780.0930
1,505.4590
1,420.6800
1,252.2720
Cost of Revenue
634.7960
634.7960
505.1070
487.0240
447.1920
Gross Profit
1,145.2970
1,145.2970
1,000.3520
933.6560
805.0800
Operating Expense
15,066.6250
15,066.6250
16,268.0670
14,405.2200
13,288.6190
Operating Income
-13,921.3280
-13,921.3280
-15,267.7150
-13,471.5640
-12,483.5390
Other Income Expense
-62.6390
-62.6390
-10,469.9190
-6,847.2680
-13,400.8580
Pretax Income
-13,983.9670
-13,983.9670
-25,737.6340
-20,318.8320
-25,884.3970
Tax Provision
--
--
--
-661.6580
--
Net Income Common Stockholders
-13,983.9670
-13,983.9670
-25,737.6340
-19,657.1740
-26,438.6840
Diluted NI Available to Com Stockholders
-13,983.9670
-13,983.9670
-25,737.6340
-19,657.1740
-26,438.6840
Basic EPS
-3.48
--
-6.98
-7.20
-44.20
Diluted EPS
-3.48
--
-6.98
-7.20
-44.20
Basic Average Shares
4,014.8480
--
3,685.9540
2,743.8020
597.5070
Diluted Average Shares
4,014.8480
--
3,685.9540
2,743.8020
597.5070
Total Operating Income as Reported
-14,084.2330
-14,084.2330
-26,033.6520
-20,428.6310
-25,360.0370
Total Expenses
15,701.4210
15,701.4210
16,773.1740
14,892.2440
13,735.8110
Net Income from Continuing & Discontinued Operation
-13,983.9670
-13,983.9670
-25,737.6340
-19,657.1740
-25,884.3970
Normalized Income
-13,833.5190
-13,833.5190
-15,087.3440
-13,086.1876
-14,067.1250
EBIT
-13,921.3280
-13,921.3280
-15,267.7150
-13,471.5640
-12,483.5390
EBITDA
-13,182.0120
-13,182.0120
-13,954.6400
-12,131.2630
-11,458.6910
Reconciled Cost of Revenue
634.7960
634.7960
505.1070
487.0240
447.1920
Reconciled Depreciation
739.3160
739.3160
1,313.0750
1,340.3010
1,024.8480
Net Income from Continuing Operation Net Minority Interest
-13,983.9670
-13,983.9670
-25,737.6340
-19,657.1740
-25,884.3970
Total Unusual Items Excluding Goodwill
-150.4480
-150.4480
-10,650.2900
-6,792.1650
-11,817.2720
Total Unusual Items
-150.4480
-150.4480
-10,650.2900
-6,792.1650
-11,817.2720
Normalized EBITDA
-13,031.5640
-13,031.5640
-3,304.3500
-5,339.0980
358.5810
Tax Rate for Calcs
--
--
--
0.0000
--
Tax Effect of Unusual Items
--
--
--
-221.1786
--
12/31/2020 - 5/3/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MHUA Meihua International Medical Technologies Co., Ltd.
0.6610
+1.69%
 
GCTK GlucoTrack, Inc.
0.4600
-3.97%
 
SAUHY Straumann Holding AG
14.84
-2.12%
 
NXGL NEXGEL, Inc.
2.2850
-1.93%
 
BNGO Bionano Genomics, Inc.
0.7590
-0.28%
 
CEOS Psykey, Inc.
0.0186
+2.76%
 
WHSI Wearable Health Solutions, Inc.
0.0008
0.00%
 
EL.PA EssilorLuxottica Société anonyme
201.60
-1.51%
 
RVP Retractable Technologies, Inc.
1.0600
-1.85%
 
OSUR OraSure Technologies, Inc.
5.26
-4.36%